11 D
Pill imprint 11 D has been identified as Zidovudine 300 mg.
Zidovudine is used in the treatment of hiv infection; occupational exposure; nonoccupational exposure; reduction of perinatal transmission of hiv and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy.
Zidovudine 300 mg is not subject to the Controlled Substances Act.
See also related documents.
Zidovudine Images
- Imprint:
-
11
D - Strength:
- 300 mg
- Color:
- White
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- hypromellose 2910 (5 mPa.s)
magnesium stearate
microcrystalline cellulose
polyethylene glycol 400
sodium starch glycolate type A potato
titanium dioxide
hypromellose 2910 (6 mPa.s)
- Drug Class:
- Nucleoside reverse transcriptase inhibitors (NRTIs)
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Aurobindo Pharma
- National Drug Code (NDC):
- 65862-0024
| NDC Code | Manufacturer / Repackager |
|---|---|
| 68084-0462 | Amerisource Health Services |
| 59762-3650 | Greenstone LLC |
| 21695-0369 | Rebel Distributors Corp (repackager) |
Note: Inactive ingredients may vary.
More Zidovudine resources
- Zidovudine (Wolters Kluwer)
- Zidovudine Capsules (Wolters Kluwer)
- Zidovudine Syrup (Wolters Kluwer)
- zidovudine (Cerner Multum)
- zidovudine injection (Cerner Multum)
- zidovudine (Micromedex) - Includes Dosage Information
- zidovudine Intravenous (Micromedex) - Includes Dosage Information
- Zidovudine (AHFS DI)
- Retrovir Infusion (FDA)
- Zidovudine (FDA)
- Zidovudine Oral Solution (FDA)
- Zidovudine Tablets (FDA)
- Zidovudine (Azidothymidine; AZT; Compound S) (Wolters Kluwer)


